Viewing nowCombinationExrofine Tablet 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hubist Pharmaceutical Co., Ltd.

MFDS item code 201607206 · Approved 2016.12.21 · Insurance code 628800860
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by single-agent treatment with amlodipine or valsartan. It effectively lowers blood pressure, reduces cardiovascular risk, and improves overall health. This treatment is suitable for individuals who have difficulty controlling their blood pressure and helps in continuous management. It is used for safely and effectively treating hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or those receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.
This drug can cause serious harm to the fetus or newborn when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or similar medications, pregnant or breastfeeding women, patients with severe kidney or liver disease, and patients with certain heart conditions should not take this medication. In patients with insufficient sodium or body fluids, hypotension may occur, so the state should be well-confirmed before taking it, and blood pressure and symptoms should be closely monitored during use. Patients with high potassium levels in the blood may have an increased risk of side effects when taking this medication with potassium-raising drugs, so regular blood tests are necessary. Patients with kidney vascular issues or those who have recently undergone kidney transplants, patients with a history of vascular edema, and patients after heart failure or myocardial infarction need special caution when taking this medication, and renal function and symptoms should be closely monitored as per the physician's instructions. During treatment with this medication, dizziness and fatigue may occur, so caution should be exercised when driving or operating machinery. Drug interactions can occur when taken with other antihypertensive or specific drugs, so all medications being taken should be fully disclosed and discussed with the physician or pharmacist. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are also advised to avoid it. The safety and efficacy of this medication have not been sufficiently established in children under 18 years of age, so it is not recommended. In the event of an overdose, blood pressure may drop too low, so it is essential to adhere to the prescribed dose, and immediate consultation with healthcare professionals is required if any abnormal symptoms occur. Regular checks on blood pressure, renal function, and electrolyte levels during this medication course are important to identify any abnormalities.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, anasarca, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste abnormalities, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nerve irritability, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, sensory loss, Stevens-Johnson syndrome, dizziness, fatigue, rapid drop in blood pressure, symptomatic hypotension, increased blood urea nitrogen, increased serum creatinine, increased BUN, airway obstruction, facial swelling, tongue swelling, pulmonary edema, angina, acute myocardial infarction, hypotension, reflex tachycardia, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be kept in a tightly sealed container. It is important to maintain the storage temperature between 1 to 30 degrees Celsius in a cool and dry place. Proper storage will ensure the medication's effectiveness.
Bright yellow egg-shaped film-coated tablet
28 tablets (14 tablets/Alu-Alu X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hubist Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.